Innovaderma logo

IDP - Innovaderma Share Price

84p 0.0  0.0%

Last Trade - 29/05/20

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £12.2m
Enterprise Value £12.1m
Revenue £14.1m
Position in Universe 1463rd / 1825
Bullish
Bearish
Unlock IDP Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the six months ended 31 December 2019, Innovaderma PLC revenues increased 33% to £5.1M. Net loss decreased 13% to £270K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Administrave expenses decrease of 3% to £699K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -£0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IDP Revenue Unlock IDP Revenue

Net Income

IDP Net Income Unlock IDP Revenue

Normalised EPS

IDP Normalised EPS Unlock IDP Revenue

PE Ratio Range

IDP PE Ratio Range Unlock IDP Revenue

Dividend Yield Range

IDP Dividend Yield Range Unlock IDP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IDP EPS Forecasts Unlock IDP Revenue
Profile Summary

InnovaDerma PLC is a holding company. The Company develops a range of male and female at-home and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation. It operates through hair and beauty division. Its products include Leimov Personal Hair Laser Starter Kit, Leimov Hair Treatment Pack, Leimov Bio Cleansing Shampoo, Leimov Thickening Conditioner, Leimov Scalp Therapy Day Treatment, Leimov Scalp Serum Night Treatment, Leimov Deep Cleansing Scalp and Body, Leimov Hair Treatment Pack for Her, Leimov Personal Hair Laser Starter Kit for Her, Leimov Vitality Shampoo, Leimov Follicle Boost Therapy, Leimov BioPlex Scalp Serum, Leimov Scalp and Body Exfoliating Spa, Leimo Instant Hair Introductory Pack, Leimo Instant Hair Regular Pack, Leimo Instant Hair Building Fiber, Skinny Tan-Ab Shader, Skinny Tan-Dermabrasion Pre-tan Primer, and Tan and Glow. It operates in the United Kingdom, the United States, Australia, New Zealand, the Philippines and South Africa.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated September 19, 2014
Public Since May 6, 2015
No. of Shareholders: n/a
No. of Employees: 41
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange London Stock Exchange (Full)
Shares in Issue 14,496,633
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IDP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IDP
Upcoming Events for IDP
Frequently Asked Questions for Innovaderma
What is the Innovaderma share price?

As of 29/05/20, shares in Innovaderma are trading at 84p, giving the company a market capitalisation of £12.2m. This share price information is delayed by 15 minutes.

How has the Innovaderma share price performed this year?

Shares in Innovaderma are currently trading at 84p and the price has moved by -9.68% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Innovaderma price has moved by 3.11% over the past year.

What are the analyst and broker recommendations for Innovaderma?

Of the analysts with advisory recommendations for Innovaderma, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Innovaderma is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Innovaderma next release its financial results?

Innovaderma is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Innovaderma dividend yield?

Innovaderma does not currently pay a dividend.

Does Innovaderma pay a dividend?

Innovaderma does not currently pay a dividend.

When does Innovaderma next pay dividends?

Innovaderma does not currently pay a dividend.

How do I buy Innovaderma shares?

To buy shares in Innovaderma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Innovaderma?

Shares in Innovaderma are currently trading at 84p, giving the company a market capitalisation of £12.2m.

Where are Innovaderma shares listed? Where are Innovaderma shares listed?

Here are the trading details for Innovaderma:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: IDP
What kind of share is Innovaderma?

Based on an overall assessment of its quality, value and momentum, Innovaderma is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Innovaderma share price forecast 2020?

Shares in Innovaderma are currently priced at 84p. At that level they are trading at 0.114% discount to the analyst consensus target price of 84.10.

Analysts covering Innovaderma currently have a consensus Earnings Per Share (EPS) forecast of 0.095 for the next financial year.

How can I tell whether the Innovaderma share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovaderma. Over the past six months, the relative strength of its shares against the market has been 56.55%. At the current price of 84p, shares in Innovaderma are trading at 28.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Innovaderma PE Ratio?

The Innovaderma PE ratio based on its reported earnings over the past 12 months is 10.67. The shares are currently trading at 84p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Innovaderma?

We were unable to find the directors for Innovaderma.

Who are the major shareholders of Innovaderma?

Here are the top five shareholders of Innovaderma based on the size of their shareholding:

Edale Capital LLP Hedge Fund
Percentage owned: 9.11% (1.32m shares)
Ward (Mark Michael) Individual Investor
Percentage owned: 5.03% (729k shares)
Aracil (Ariadna Greñan) Individual Investor
Percentage owned: 4.04% (586k shares)
Bayer (Joseph) Individual Investor
Percentage owned: 1.44% (209k shares)
Andrews (Ross Martin) Individual Investor
Percentage owned: 0.65% (94.9k shares)
Similar to IDP
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.